[1]
“Thyroid Dysfunction in Chronic Hepatitis C Patients Treated with Pegylated Interferon Alpha 2a and Ribavirin Combination Therapy and its Predisposing Factors”, J Fatima Jinnah Med Univ, vol. 8, no. 2, Nov. 2018, Accessed: Apr. 10, 2026. [Online]. Available: http://jfjmu.com/index.php/ojs/article/view/131